Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Balyasny Asset Management L.P.

Balyasny Asset Management L.P. trimmed its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 41.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,689 shares of the company's stock after selling 2,624 shares during the quarter. Balyasny Asset Management L.P.'s holdings in Addus HomeCare were worth $462,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Barclays PLC boosted its holdings in shares of Addus HomeCare by 204.8% during the third quarter. Barclays PLC now owns 43,470 shares of the company's stock worth $5,783,000 after purchasing an additional 29,207 shares during the last quarter. Ellsworth Advisors LLC increased its stake in shares of Addus HomeCare by 6.5% during the 4th quarter. Ellsworth Advisors LLC now owns 5,692 shares of the company's stock valued at $713,000 after acquiring an additional 348 shares during the last quarter. Sheets Smith Wealth Management lifted its holdings in shares of Addus HomeCare by 3.2% during the 4th quarter. Sheets Smith Wealth Management now owns 7,005 shares of the company's stock worth $878,000 after acquiring an additional 218 shares during the period. Dakota Wealth Management boosted its position in shares of Addus HomeCare by 24.2% in the fourth quarter. Dakota Wealth Management now owns 2,024 shares of the company's stock worth $254,000 after acquiring an additional 394 shares during the last quarter. Finally, Janney Montgomery Scott LLC grew its holdings in Addus HomeCare by 0.9% in the fourth quarter. Janney Montgomery Scott LLC now owns 10,691 shares of the company's stock valued at $1,340,000 after purchasing an additional 91 shares during the period. Institutional investors and hedge funds own 95.35% of the company's stock.

Addus HomeCare Stock Performance

Shares of ADUS stock traded down $2.17 during trading hours on Wednesday, hitting $110.34. 85,533 shares of the company were exchanged, compared to its average volume of 165,748. The stock has a market capitalization of $2.03 billion, a price-to-earnings ratio of 25.29, a P/E/G ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a one year low of $88.96 and a one year high of $136.72. The business's 50-day simple moving average is $101.10 and its two-hundred day simple moving average is $113.55.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $337.71 million during the quarter, compared to analyst estimates of $341.66 million. During the same quarter in the previous year, the firm earned $1.21 earnings per share. The firm's revenue for the quarter was up 20.3% compared to the same quarter last year. As a group, analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the stock. Stephens reiterated an "overweight" rating and issued a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. JMP Securities reissued a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday, April 22nd. StockNews.com downgraded Addus HomeCare from a "buy" rating to a "hold" rating in a report on Wednesday, February 26th. Macquarie boosted their target price on Addus HomeCare from $129.00 to $133.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Finally, Oppenheimer increased their target price on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. One analyst has rated the stock with a hold rating, six have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $142.57.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.